This FAQ breaks down the AAP's newest COVID-19, RSV, and influenza recommendations for clinicians who want a quick refresher on what changed for the 2026-2027 season.
|Podcasts|January 14, 2021
Diagnostic Update in Tuberculosis Testing for Children
Dr Anna Mandalakas, professor of pediatrics and tropical medicine at Baylor College of Medicine in Houston, Texas, looks at the 2 screening methods available for latent tuberculosis in children, what the preferred tests have been according to the American Academy of Pediatrics Red Book, and a new study that takes a look at both testing methodologies, to compare efficacy.
Advertisement
Advertisement
Related to this article
XOCOVA gives pediatricians a new oral option to help prevent COVID-19 after exposure in adolescents aged 12 years and older.
An updated AAP policy statement renews the call to ban raw milk sales, citing pathogen risks to children and pregnant people and an emerging H5N1 concern.
At AAP 2026, Rana Hamdy, MD, discussed when to test children for group A strep, antibiotic selection, and strategies to improve prescribing.
Jonathan Miller, MD, discusses earlier HPV vaccination, individualized conversations with hesitant families, and strategies to improve vaccine uptake.
Jonathan Miller, MD, discusses factors behind lagging HPV vaccination rates and how pediatricians can address common parent concerns.
The latest IDSA histoplasmosis update adds a consensus statement on severe disease and outlines when children with pulmonary infection warrant itraconazole therapy.
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
Type 1 diabetes update: Immune therapy, screening, and new technology
2
Adolescent suicidal ideation trend reversed around 2009, analysis finds
3
Constipation may be an overlooked driver of urinary symptoms in children
4
What pediatricians should know about the 2026-27 AAP vaccine schedule
5